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Objcztbes. This study was desigaed to investigate disturbances 
in arterial blood pressare and body fluid homeostasis in stable 
beer! traasplant recffdea(s. 
Backgmund Hypettensioa and fluid retention frqaently com- 
plicate heart traarplaatation. 
h&t/m& Blood pressure, renal and eadocrk respoases to 
acute volume expaasion were compared in 10 beart hasplaat 
redpients(~7-cByearsoM[81488fSD])Mf5~~BffeT 
traasplantatiox, 6 liver hasplant recipients receiviag similar 
doses of cyclosporiue (cyclesporiae couth group) aad 7 aormal 
volunteers (aormal control subjects). After 3 days of a cons&at 
diet contaioing 87 mE@4 II of sodium, 0.154 molhiter sak was 
infusedatSmVltgpcrLfor4b.Bloodpressnrraad~ 
vasoprwsia, aagioleash Q aldos~ atrial natiuretic peptide 
and renia activity kvels were determined before aud at 3& 6d, IM 
BBd248mindorisgtbeiaCnsioaUrioewaseoUededatZawl4h. 
llloodpressare,flltidbahmcebowmneanndreMlfunction~ 
mooitorcd for 48 b after tbe iahion. 
i’tesuh. Blood pressure did not chaage in the two control 
groups but increased in the heart transptant recipients (+I5 + 
818 -C 5 mm Hg) and remained elevated for 48 II (p I 6.95). Uriue 
flow and urinary sodium excrctioo imreased ahruutty in the 
amtrol groups suEicient to account for clieinatioa of 86 * 9% of 
tbesodiumioad$48B;tbeiaawses arrrbhmted(p58.851aad 
delayed in the heart twnspbt tvzcipiea& ttsulfing in elimiaatioa 
ofordy~l~i3%oftksodiwnhad.SaMaehtbsiof4sappremed 
wwprwsi~reninoctivity,~sbllland-intbc 
twocolltrolgroups(pc~.rJ5)butaotiathepaFt~t 
recipieats. Heart traaspkt recipkw had eievatcd atrial aatri- 
areticpeptidekvelsatbaselke(p~tJJJS),butrelat&eiacrwes 
duriagtheiafwiaaweresimihrtotbowiabotbcoatrulgnmps. 
CBkEhlSiW.B~presSIlRhhWJttMsplaut~ts* 
saltseasithTbesepatieatsbaveablunteddiar&icaudnatri- 
weticre.spowtovolume~ tbtlt~~bCtiH!dkd~~ 
fniluretoivlledysupprwsflnidregalatory~~ 
d&ctsinLdoodpresswandtlaidhoox&a&wereaatseeaiin 
livertrrlMplantreEipieatr~cycIosporiacMdths¶v!fore 
canMtbe-to~ae*-- 
-~secasdprJltO~dosen;ltiogEW~ 
contrihate to salt5ensitive ItypeWAi and thdd retentioa in 
heart transplant lw&iwts 
(J Am coil ciudial i9%$7:375-83) 
Hypertension is a nearly universal complication of heart 
transplantation. Heart transplant hypertension is unrelated to 
preexisting hypertension (l-3) and is characterized by an 
expansion of extracellular kid volume (4). Cyckuporine has 
been proposed as the cause of heart transplant hypertension, 
fluid retention and renal damage (5-10). However, hyperten- 
sion in heart transplant recipients is more severe than in other 
populations receiving cyclosporine (l-3). Moreover, reduc- 
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tions in cyclosporine dose, serum concentration and duration 
of therapy fail to reduce the incidence of hypertension despite 
improved renal function (l-3). Filly, heart tramphmt recip- 
ients who never receive cyclosporme also have a high in&fence 
of hypertension (2). Other studii have implicated cyclosporine- 
mediated sympathoexcitation in transplant hypertension. In- 
deed, indexes of sympathoexcitation are more pronouuced in 
heart transplant recipients than in other tramplant recipients 
(11). but this also occurs even in the absence of cydospotine 
(12). Against this background, it seems possible that hyperten- 
sion and fluid retention, in these patients may extend beyond 
“cyclosporine-related” mechanisms 
An alternative explanation is that heart transplant recipi- 
ents have abnormal cardiorenaf neural reflexes secondary to 
cardiac denervation. Cardiac vohrjne receptor% subserved by 
wgal atferents, respond to fluid expansion by reflexly suppress- 
ingatghinev~ re~eoronc, thirst 
atKIsympathetieneuraItla8ictotbekidney.fhus~ 
diurwis and natriurcsis (13,14). In @ cardiac denervation 
diminishes the diuretic and natriuretic responxs to acute 
irrss-m97is66t5.m 
073slw7(9Qiw67-x 
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T&k 1. Descriptive Characteristics, Indexes of Renal Function and 
Immunosuonression Repjmen in the Normal Control, Liver 
Transplan~kl Heart Tiansplant Groups 
atherosclerotic disease, and none of the heart transplant 
recipients had any evidence of cardiac allograft vascular dis- 
ease. 
control 
GONp 
(a = 7) 
Liver 
Transplant 
Group 
(n = 6) 
Hi%t 
Transplant 
GlOUP 
(n = ll?) 
Merhmcn 611 3i-3 8E 
&eQ 60.9 -c 9 51.0 + 6 57.4 : 9 
Height (cm) 173.4 2 9 169.7 2 10 171.8 2 9 
weisht @8) 77.2 2 15 75.2 2 13 88.5 c 15 
MO after transplantation - 13.4 + 8 m.7 c 5 
!3cnmt creatinine (mgidl) 1.1 2 0.2 1.7 + 0.4’ 1.4 z 0.4’ 
Creatininc karance (ml/min) 93.9 2 24 66.8 t 11’ 81.6 I 31’ 
~(mgR4h) - 300 + 35 325223 
F’redahne ImU24 h) .~ 8.3 2 1 8.5 2 2 
‘p c 0.05, heart and liver IraqIant groups wws control group. Data 
presented are mean value 2 SD or number of patients. 
volume expansion (15-17). In conscious primates, cardiac 
denervation attenuates urine Bow and sodium excretion and 
causes arterial hypertension (18). In heart transplant recipi- 
ents, renal responses to volume expansion are absent early 
after transplantation (19), and vasopressin and the renin- 
angiotensin-aldosterone axis are not reflexly suppressed in the 
supine posture (20) or by water immersion (12). 
These findings led us to hypothesize that cardiac denerva- 
tion may interrupt key neural and humoral homeostatic mech- 
anisms that normally adjust sodium and fluid excretion to 
changes in intake. Such an interruption, especially if combined 
with endothelial dysfunction from cyclosporine administration 
(9,10), could lead to an extreme form of salt-sensitive hyper- 
tension. To test this hypothesis, we contrasted the arterial 
blood pressure, renal and endocrine responses to an intrave- 
nous saline load in heart transplant recipients (cardiac dener- 
vation plus cyclosporine), in liver transplant recipients (cardiac 
innervation plus qclosporine) and in normal control subjects. 
Methods 
Sdjeets. The clinical characteristics of the three groups 
are presented in Table 1. The transplant recipients were 
clii stable and free from significant rejection, infection or 
other major illness. AU heart and Liver transplant recipients 
received immunosuppressive therapy with cyclosporine, pred- 
Gone and axathioprine. All transplant recipients were receiv- 
ing maintenance prednisone of 5 to 10 mg/day at the time of 
the study, and no transplant patient had required enhan+ 
corticosteroid doses within 6 months of the study. Whde- 
blood Hospoke trough levels, calculated as an average of 
four determinations over 6 months before the study, were 
similarintheheart(238It26nghnl[mean~SD])andiiver 
(2412 31 @ml) transplant recipients. None of the transplant 
recipients were hypertensive before transplantation, but all 
received a&hypertensive agents for management of hyperten- 
sion after transplantation. None of the subjects had evidence of 
Diuretic drugs were discontinued 10 days before the study; 
angiotensinconverting enzyme inhibitors and calcium channel 
blocking agents were discontinued 4 days before the study. No 
alpha- or beta-adrenergic Mock& &gents or ather cardiac 
medications were used ‘cJ the transplant recipients. None of 
rhe carma control subjects received medication at the time of 
the srudy. The protocol was approved by the institutional 
review board for the protection of human subjects at the 
University of Florida College of Medicine, and all subjects 
provided their written informed consent to participate in the 
study. 
Control period. Subjects did not add salt to their usual diet 
for 4 dzys before admission to the hospital. Thereafter, they 
were admitted to the Clinical Research Center, Shands Hos- 
pital, at the University of Florida, for 6 days. The first 3 days 
were an equilibration to the controlled diet that consisted of 
suflkien: calories to maintain their current weight and pro- 
vided 87 mEQ/24 h of sodium and 80 mE+/24 h of potassium. 
This diet was served as three meals taken at 8 AM, 12 PM and 5 
PM. Water was restricted to 1,000 ml on day 3 but was provided 
ad libitum on all other days of the study. Consumption of 
alcohol, caffeine and tobacco products was not allowed. 
Subjects were awakened each morning at 7 AM, and, while 
they were still supine, blood pressure was recorded in triplicate 
using an automated system (Datascope Corp.), and blood 
samples were drawn from an indwelling venous catheter for 
analysis of plasma concentrations of vasopressin, angiotensin 
II, aldosterone, atrial natriuretic peptide and renin activity. A 
24-h urine collection was started each morning at 7 AM. Au 
subjects had ?lO% of sodium balance before the salii 
infusion studies conducted on day 4. 
Hemodynamic variables and left ventricular fun&ion. 
Data defining each cardiac transplant recipient’s hemodynamic 
status and left ventricular function were obtained from routine 
right heart catheterization using standard thermodihrtion tech- 
niques and routine follow-up two-dimensional echocardio- 
graphic examinations performed in the cardiac catheterization 
laboratory and echocardiography laboratory at Shands Hospi- 
tal at the University of Florida within 6 months of the present 
study. These data are shown in Table 2. 
Expwbeatal protoeol. On day 4, the blood pressure, renal 
and endocrine responses to saline infusion were determined. 
AL 7 AM the subject was awakened, blood samples were 
obtained, ,and the subject then stood and voided. Creatinine 
clearance was determked from the 24-h sample. After 1 h, the 
subject again voided and returned to a supine posture and 
remained supine until completion of the infusion. Isotonic 
saline (0.154 moVliter) was infused at 8 ml/kg per h for 4 h. 
Blood pressure, heart rate and blood samples for iIuid balance 
hormones were taken before the infusion and at 30,60,120 
and 240 min during the. infusion. Urine was coileeted at 2 and 
4 h during the infusion with the subject supine. After comple- 
tion of the infusion, an 8-h urine collection was started. 
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TaMe 2. HetnT.namic Variables and Left Ventricular Function at Supine Rest in Heart 
Transplant Rectplents 
-_-_ 
Pt Mean RAP Mem I A0 CI Szptllm PH; ~ EF 
NO. (mm Hg) (mm Hg) fllterv‘min pe: m’j (mm) Imm) (7) 
1 x 21 1.73 8 7 ho 
7 I IX 3.73 x 10 NJ 
3 5 II NA II I? 55 
4 6 10 3.43 IO 11 55 
5 x I? 1.x2 :‘A NA 65 
6 NJ 14 2.4 Y 10 NJ 
7 n x 2.14 II II 46 
x 6 4 ?.4’ r 4 hcJ 
Y 6 13 !.%I 10 10 5x 
III 6 8 I.% J 0 5s 
Mean 70 11.9 2.h 9.3 V.V 57.4 
ISD 2 1.4 24.9 ?0.7c; fJ.2 r1.4 ri.l 
Cl = cardiac index; EF = ejection fraction: PAD = pulmonq arte~ wcludtld pressure; pt = pat&r: PW = 
pserior wntricular wall thickness: RAP = right atria1 prrsurr: .%ptum = ventricular vplal thxknes. 
Thereafter, 12-h urine collections were performed until the 
completion of the study. The 7 AM sample collection described 
earlier was repeate! on days 5 and 6. The sampling regimen 
provided 48 h of observation for blood pressure, renal salt and 
water elimination and fluid regulatory hormones after onset of 
the volume stimulus. 
RIoud sampIe c&etion. Blood samples for vasopressin, 
plasma renin .&vity, angiotensin II, aldosterone and atrial 
natriuretic peptide assays were drawn into ethylene vacutainers 
containing EDT& Plasma was separated by centrifugation at 
3,000 x g at 4°C for 20 mitt, and the samples were frozen at 
-70°C until the assays were performed. 
covariance (ANCOVA) with repeated measures was used to 
analyze the temporal pattern of all hemodynamic. renal and 
endocrine responses to the saline infusion. When a significant 
group-by-time interaction was observed, within-group compar- 
isons between time points and between-group comparisons at 
each time point were done using ANCOVA with contrast 
analysis for obtaining appropriate post hoc custom hypothesis 
tests. All statistical analyses were performed using tbe SAS 
stattstical program (SAS Institute Inc.). An alpha level of p = 
0.05 was required for statistical signLicance. 
Laboratory tecItnIques. Plasma vasopressin was measured 
by radioimmunoassay as previously described (21). L,&rna 
renin activity was determined by radioimmunoassay usmg a 
modification of the method of Haber et al. (22). Plasma 
angiotensin 11 and aldosterone levels were determined by 
radioimmunoassay as previously described by Braith et al. (23). 
Atria1 natriuretic pep’tde was extracted from plasma using a 
modification of a tecmique described by Hatjis et al. (24). 
Plasma (I ml) was deproteinized by adding 750 111 of 0.1 
moMiter acetic acid and 1.25 ml methanol. Samples were 
placed on a rocking shaker for 10 min, followed by centrifu- 
gation for 20 min at 6.000 rpm at 4°C. The supematant was 
dried by vacuum centrifugation. Radioimmunoassay w-s per- 
formed with a kit from Peninsula Laboratories using atrial 
natriuretic neptide antiserum that has 0% cross-reactivity with 
human brain natriuretic peptide and C-type natriuretic pep 
tide. 
Results 
BIoad presstsre respaasrs. Untreated systolic and diastolic 
blood pressure in the heart transplant recipients (149 t 
13/93 2 6 mm Hg) were significantly higher (p d 0.05) than 
that in the liver transplant recipients (133 -t I6/82 ‘t 
13 mm Hg) and normal control subjects (I 16 5 12/69 + 
11 mm Hg). Relative changes in blood pressure responses to 
volume expansion are presented in Fire 1. During the 4-h 
saline inbtsion, systolic and diastolic pressure did not change in 
the liver transplant recipients and normal control subjects. In 
contrast, both systolic (t 15 2 8 mm Hg) and diastolic pressure 
(t8 ? 5 mm Hg) increased (p 5 0.05) progressively through- 
out the infusion in the heart transplant recipients, At 48 h after 
the infusion, both systolic and diastolic blood pressure re- 
mained elevated (p c 0.05) above baseline values in the heart 
transplant recipients 
Sodium and potassium concentrations in urine and plasma 
were measured using a Nova I electrolyte analyzer (Nova 
Biomedical). Plasma osmolality was measured with a vapor 
pressure osmometer (Wescor Inc.). Standard methods were 
used for the measurement of serum creatinine and the caku- 
lation of creatinine clearance. 
f$tatistid t4sidy& Descriptive characteristics were eom- 
pared among groups using amdysis of ,varmnce. Analysis of 
RenaI responses. The temporal patterns of urine volume 
and urinary salt excretion are presented in Figure 2 Urine 
volume during the 6h saline infusion increased similarly in all 
three groups. However, urine volume at 12 and 24 h after 
infusion was signiftcantIy @ C: 0.05) &ninished in the heart 
transplant recipients. The net urine output over ci8 h was 63 t 
14 ml& this was signihcantly (p I 0.05) less than the 
corresponding vahtes of 80 2 15 ml/kg for normal control 
subjects and 77 * 12 ml&g for l&r tmmplant recipiints. 
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0 .5 1 2 4 +24 +48 
TIME (br) 
Figure 1. Changes (A) in systolic and diastolic blood pressure during 
a 4-h infusion of isotonic saline and the 48-h period after the infusion. 
Data are mean value z SEM. ‘p s 0.05 versus baseline value. ip 5 
0.05, heart transplant recipients versus liver transplant recipients and 
normal control subjects. 
The urinary salt excretion increased in all groups. However, 
in heart transplant recipients, salt excretion wa significantly 
(p d 0.05) reduced during the 4-h saline infusion and remained 
Fiire 2. Changes in urine flow rate (UV) and urinary salt excretion 
(UnaV) during a 4-h infusion ot isotonic saline and the 48-h period 
after the infusion. Data are mean value 2 SEM. ‘tp c 0.05, heart 
transplant recipients versus liver transplant recipients and normal 
contrkl subjrcts. 
0 2 4 12 24 36 48 
TIME (br) 
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Fire 3. Changes in plasma salt concentration and plasma osmolality 
(Osm) during a 4-b infusion of isotonic saline and the 48-h period after 
the infusion. Data are mean value + SEM. ‘p s 0.05 versus baseline 
value. ip 5 0.05, heart transplant recipients versus liver transplant 
recipients and normal control subjects. 
significantly (p 5 0.05) diminished, compared with the other 
ms groups, until 36 b after the infusion. A delayed natriuresis 
(p 5 0.05) was recorded in the heart transplant recipients 
during the final 12-h collection period. Overall, the heart 
transplant recipients excreted 51 2 13% of the sodium load by 
48 h. This was significant!y less than the corresponding values 
of 87 2 8% in normal control subjects and 85 rt_ 10% in liver 
transplant recipients. Salt retention in the heart transplant 
recipients was reflected by trarkent increases (p 5 0.05) in 
plasma sodium concentration and plasma osmolality (Fig. 3). 
Endocrine responses. Baseline plasma renin activity, an- 
giotensin II and aldosterone were not different among the 
control (2.0 2 1.2 nglml per h; 3.5 -+ 0.6 pglml; 133 2 
46 pghl), heart transplant (3.5 + 0.8 nglml per h; 5.5 Z 1.0 pg!mk 
160 ? 27 pgiml) and liver transplant groups (2.9 t 1.4 @ml 
per h; 4.2 rt 0.8 &ml; I38 + 12 @ml). Changes in the 
renin-angiotensin-aldosterone system during volume expan- 
sion are presented in Figure 4. Saline infusion suppressed 
plasma renin activity, angiotensin II and aldosterone well 
below baseline (p 5 0.05) at all measurement p+?riods in the 
liver transplant recipients and normal control subjects; the 
renin-angiotensin-aldosterone axis returned slowly toward 
baseline over the next 48 h. Remarkably, plasma renin activity, 
angiotensin II, and aldosterone in heart transplant recipients 
showed no trend toward a reduction during the infusion, and 
levels remained above those of the two control groups through- 
out the 48-h observation period (p B 0.05). 
Baseline vasoprekn levels were not different among the 
control (2.9 T 0.6 pg/ml), heart transplant (3.6 4 I.1 pg/mI) 
and liver transplant (2.9 -t 0.4 pg/rnl) groups. In liver Pans- 
JACC Vol. 27. No. 2 
F&my 1996:375-83 
a l 
S A L I N E  INFUSION 
!  ’ .  
--_ 
0 .S l& (hr; +24 +48 
Figure 4. Changes (A) in plasma renin activity (PRA). plasma angio- 
tensin II concentration (ANG II) and plasma aldosterone concentra- 
tion (ALDG) during a 4-h infusion of isotonic saline and the 48-h 
period after the infusion. Data are mean value + SEM. *p 5 0.05 
versus baseline value. tp 5 0.05, heart transplant recipients versus liver 
tramplant recipients and normal control subjects. 
plant recipients and normal control subjects, vasopressin con- 
centrations were significantly suppressed below baseline at 
30 min after onset of the saline infusion and remained 
suppressed over 48 h (Fig. 5). Conversely, vasopressin levels in 
heart transplant recipients were elevated (p 5 0.05) above 
baseline during the infusion, and they remained above the 
values in the two control groups throughout the period of 
observation. This paradoxic rise in vasopressin appears related 
to an inabiity to reflexly suppress arginine vasopressin and also 
to the signilicant increase in plasma osmolality (Fig. 3). 
Baseline atrial natriuretic peptide levels were elevated (p 5 
0.05) in heart transplant recipients (52 t 16 pg/ml) compared 
with that in liver transplant recipients (22 c 5 p&ml) and 
normal control subjects (16 + 4 dml). However, volume 
expansion eliiited comparable increases in atrial nattiuretic 
peptide among the three groups (Fig. 5). Atrial nattiuretic 
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8 .S II 2 4 +24 +48 
TnvIE (Id 
Figure 5. Changes (A) in plasma arginine vasopressin concentration 
(AVP) and plasma atrial natriuretic peptide concentration (ANP) 
during a 4-h infusion of isotonic saline and the 48-h period after the 
infusion. Data are mean value + SEM. *p 5 0.05 versus baseiine value. 
tp c 0.05, heart transplant recipients vuws liver transplant recipients 
and normal control subjects. 9p 5 0.05, heart transplant recipients 
versus liver transplant recipients and normal control subjects at 
baseline. 
peptide levels increased twofold at the conclusion of the 4-h 
infusion. and they returned to baseline levels within 24 h in all 
groups. 
C&liar responses. Volume expansion with isotonic saline 
elicited a significant baroreflex-mediated decrease in supine 
rest heart rate in the normal control subjects (61 -C 4 to 56 5 
4 beats/min) and in the liver transplant recipients (63 2 5 to 
58 f 4 beats/min). However, rest heart rate in the heart 
transplant recipients did not change during the 4-h infusion 
(78 + 6 to 78 -C 7 beatsjmin), and heart rate remained constant 
throughout the 48-h postinfusion observation period. 
To exclude a nossible influence of cardiac function on 
differences in salt and water handling in heart versus liver 
transplant recipients, we reviewed cardiac index in heart 
tramplan: recipients during their most recent complete right 
heart catheter&Con. The mean cardiac index for the heart 
transplant recipients waT2.54 + 0.7X liters/min per mz (normal 
cardiac index is 2.4 to 3.5 IitersJmin per m’). 
Adverse responses. The protocol was discontinued in two 
additional heart transplant recipients, and their results were 
excluded from the data analysis. In one patient, blood pressure 
increased progressively ( >IXICJ/l 10 mm Hg supine) during the 
3&y control period. Antihypertensive therapy was returned 
and the patient was discharged from the Clinical Research 
Center without receiving the saline infusiin. A second heart 
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transplant recipient had normal baseline blood pressure 
(139/90 mm Hg supine), but vohime expansion with saline 
elicited a severely hypertensive response (197/l 15 mm Hg). 
and the infusion was stopped at 2 h. These findings highlight 
the severity of hypertension in heart transplant recipients and 
emphasize that salt loading can lead to potentially dangerous 
increases in arterial blood pressure. 
Discussion 
Principal findings. There were three main findings of this 
study: 1) Arterial blood pressure in heart transplant recipients 
is salt sensitive. Blood pressure in liver transplant recipients 
and nonnal control subjects did not change during. saline 
infusion, but both systolic (t15 -C S mm Hg) and diastolic 
pressure (+8 ? 5 mm Hg) increased significantly in the heart 
transplant recipients during the infusion and remained elc- 
vated for 48 h. Severe hypertensive responses (blood pressure 
>200/110 mm Hg) caused us to stop the protocol in two 
additional heart transplant recipients who were consequently 
excluded from the data analysis. 2) Heart transplant recipients 
demonstrate blunted and abnormally abbreviated diuresis and 
natriuresis in response to volume expansion; this occurs de- 
spite a persistent increase in blood pressure, which normally 
leads to a brisk natriuresis and diuresis. Liver transplant 
recipients and normal control subjects eliminated 85% and 
87% of the salt load, respectively, within 48 h after the 
infusion. In contrast, the heart transplant recipients ebminated 
only 51% of the salt load in 48 h. The blunted natriuresis 
occurred despite elevated baseime atrial natriuretic peptide 
and normal atrial natriuretic peptide increases during volume 
expansion. Higher renal perfusion pressures should have en- 
hanced the diuretic and natriuretic responses to atria1 natri- 
uretic peptide. 3) The avid salt and fluid retention in the heart 
transplant recipients was accompanied by a failure to reflexly 
suppress arginine vasopressin and the renin-angiotensin- 
aldosterone axis. These results demonstrate very abnormal 
regulation of biood pressure and body fkJid homeostasis in 
heart transplant recipients compared with that in normal 
control subjects and liver transplant recipients receiving similar 
doses of cyclosporine. 
Respoases e&y and late after transptantztiin. In the only 
previons study of renal responses to saline infusion in heart 
transplant recipients late after transplantation (7 2 2 months), 
Pruszcxynski et al. (25) reported normal diuresis and natriure- 
sis during the infusion. However, these investigators collected 
renal data for only 3 h. Thus, they probably recorded the brief 
period of pressure diuresis and natriuresis that we also ob- 
served within the first few hours after starting the infusion. The 
kmger period of observation in our study revealed the very 
abbreviated nature of the response after volume expansion 
with saline. In this connection, Singer et al. (26) found that a 
S-day high salt diet fails to evoke appropriate suppression of 
plasma renin activity and aldosterone in heart transplant 
recipients and causes an increase in blood pressure, Addition- 
a&, their Iindings concur with our observation that blood 
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pressure af’er heart transplantation is very sensitive to dietary 
sodium intake. Supine blood pressure in the heart transplant 
recipients was significantly increased on the high salt diet 
(148/97 mm Hg, 350 mmo1124 h sodium) compared with the 
low salt diet (137/94 mm Hg, 10 mmoV24 h sodium). Mean 
increase in systolic pressure was 12 * 5 mm Hp. There was a 
much smaller increase in systolic pressure in changing from 
low to high salt intake in the healthy control subjects (increase 
of 5 2 2 mm Hg). 
Our findings in patients late after transplantation are 
conststent with previous studies early after transplantation. 
Mertes et al. (19) found that heart transplant recipients 1 to 5 
days after operation were unable to increase renal water and 
sodium excretion after volume expansion with Ringer’s lactate 
solution. The blunted renal response was accompanied by 
failure to reflexly suppress vasopressin and the renin- 
angiorensin-aldosterone axis. Wilkins et al. (27) also reported 
the absence of diuretic and natriuretic responses during lower 
body positive pressure with medical antishock trousers. This 
maneuver raises atria1 pressure through displacement of ve- 
nous blood into the central circulation and increases urine 
output and urinary salt excretion in control subjects with intact 
cardiac nerves. Similarly, Myers et al. (12) reported sodium 
retention after water immersion in heart transplant recipients, 
suggesting that cardiac innervation is necessary for the appro- 
priate natriuretic response to central volume expansion. 
Hemodynamk variables and left ventricular function. Al- 
though strong clinical evidence exists to suggest occult diastolic 
dysfunction in chronic, clinically stable heart transplant recip- 
ients (28), our (29) and the other previously published data (3) 
and the hemodynamic findings of the present study all indicate 
that cardiac index at rest is maintained within the normal 
range, albeit genera!ly toward the lower end of the normal 
range. The echocardiographic findings in our heart transplant 
recipients do not indicate abnormal hypertrophy and confirm 
normal left ventricular systolic function (Table 2). Thus, the 
hemodynamic response to volume expansion in the heart 
transplant recipients, a oreload-dependent population, should 
be a moderate increase in rest cardiac index, if anything. 
Further clinical evidence for this is the absence of any baroreflex- 
mediated decline in heart rate in the heart transplant recipt- 
ents as well as the noted rise in systolic blood pressure. In 
summary, with normal systolic function and well maintained 
heart rates, volume expansion in this cohort should enhance 
forward cardiac output, not decrease it. Thus, ‘the abnormal 
salt and water handling that we observed in our heart versus 
liver transplant recipients cannot be attributed to differences in 
forward cardiac output. 
Cyclasporlne and renal function. Most reports of trans- 
plant hypertension and fluid retention have emphasized 
cyclosporine-induced nephrotoxicity (5-8) and endothelial 
dysfunction (9,lO). The adverse effects of cyclosporine include 
an increase in renal vascular resistance and a concomitant 
decrease in glomerular filtration rate and renal blood tlow, 
these effects are clearly associated with hypertension and fluid 
retention. In the present study we relied on the semiquantita- 
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tive estimate of glomenrlar filtration rate using endogenous 
creatinine clearance. AIthough this technique may not be 
sufficiently sensitive to detect small differences in filtration rate 
between groups, our data LctuaIly indicate a trend toward 
better glomerular filtration rate in the heart transplant recip- 
ients than that in the liver transplant recipients (Table 1). 
Interestingly, resolution of posttransplant hypertension after 
liver transplantation occurs despite impaired glomerular filtra- 
tion, suggesting that impaired glomerular filtration rate is not 
sufficient to explain de novo hyperteusion after organ trans- 
plantation (30). Furthermore, hypertension in heart transplant 
recipients frequently develops within 1 month of transplsnta- 
tion, before nephrotoxicity is observed, and the progression of 
hypertension does not correlate with changes in renal ft. +n 
(3). Reduction in cyclosporine dose improves renal fuuc++~, 
but the incidence and severity of hypertension remain un- 
changed in patients treated with a high or low dose regimen 
(23.7). The duration of 9cIosporine therapy does nti: corre- 
late with the severity of hypertension (1,2,7). Renal vascular 
resistance is elevated by cyclosporiee, but it is also significantly 
elevated in heart transplant recipients who have never received 
cyclosporine (12). In addition, hypertension in heart transplant 
recipients is more severe and resistant to antihypertensive 
drugs than in other populations ,receiving cyclosporine 
(1,2,11,25). Perhaps the most compelling argument for an 
alternative mechanism in transplant hypertension is that heart 
transplant recipients who have never received 9cIosporine 
also have a high (60%) incidence of hypertension (2). 
Cyclospcrine is also reported to increase muscle sympa- 
thetic nervous activity, but the magnitude of sympathetic 
nervous discharge and plasma norepinephrine levels are sig- 
nificantly greater in heart transplant recipients than in other 
patients taking similar doses of cyciosporine (11). Moreover, 
the nocturnal decline in blood pressure Seen in both normo- 
tensive and hypertensive individuals is absent after heart 
transpiantation, suggestmg that cardiac denervation modulates 
the circadian variation in blood pressure (31). These findings 
suggest that the unique abnormalities of cardiorenal neural 
reflex regulation that we have described in heart transplant 
recipients derive from the combination of a dea?Ierented heart 
that fails to detect fluid volume expansion and appropriately 
modify the sympathetic nervous system response and, sec- 
ondly, from the use of 9closporine, which further accentuates 
the abnormal sympathetic nervous system discharge. Our 
findings of normal blood pressure and body fluid homeostasis 
in liver transplant recipients who also are treated with 9clo- 
sporine show clearly that 9closporine usage alone is an 
,inadequate exphmation for the counterhomeostatic responses 
detect4 in the heart transplant recipients. 
Caedhic d+TereatatIon. Viewing the transplanted heart as 
a deatIerented ‘Volume-sensing” organ provides an alternative 
explanation for the ineidenoe of hypertension in this patient 
group. Our results and those of others (3,4,12,20) argue that 
the cardiorenal neuroendoerine reflex mechanism of volume 
regulation is abnormal in heart tmnspknt recipients AbIation 
of cardiac alIerent input should disiu.hiit the cardiomnaf 
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reflex, increase renal nerve activity and renal vascular resis- 
tance, reduce gIomerular filtration rate and increase vasopres- 
sin, plasma renin activity, angiotensin II and aldosterone. 
These effects should impair the ability to excrete salt and 
thereby increase blood pressure. Indeed, heart transplant 
recipients frequently require diuretics even after normalization 
of cardiac hemodynamic variables (3,4). Plasma volume in- 
creases of 15% are reported in hypertensive heart transplant 
recipients (4), and a fluid volume increase of only 3% to 4% 
can theoretically result in sustained hypertension (32). Despite 
this increased plasma volume, vasopressin levels are not sup- 
pressed during the supine posture (20), and plasma renin 
activity and renal vascuiar resistance are not reflexly sup 
pressed by water immersion (12). 
Failure to suppress vasopressin and the renin-angiotensin- 
aldosterone system could play a critical role in the abnormal 
blood pressure and fluid homeostasis in heart transplant 
recipients. Unopposed or enhanced efIerent sympathetic nerve 
traffic, secondary to cardiac deafferentation, could stimulate 
renin secretion as well as promote a direct activation of 
alpha-adrenergic receptors Iocated on the renal tubules that 
enhances sodium retention independent of the renin- 
angiotensin-aldosterone system (33). We did not measure 
plasma norepinephrine iu the present study, but it is unhkely 
that peripheral venous norepinephrine levels couki provide 
evidence of potentiated renal sympathetic nerve stimulation. 
However, persistent elevation of renal vascuhar resistanos that 
is predominantIy postglomendar is reported in heart trans- 
plant recipients, suggesting that they have unopposed or 
enhanced efferent sympathetic nervous traffic to their renaI 
vasculature (12). 
AtrIaI natiuretk peptIde. AtriaI natriuretic peptide was 
elevated in our heart transplant recipients, and tinir is a 
consistent finding in heart trancplant patients (23.34). How- 
ever, e!evated levels of atrial natriuretic peptide failei to 
mitigate the blunted natrimesis. The renal refractoriness to 
atrial natriuretic peptide may reflect the effects of chronicaIIy 
elevated atria1 natriuretic peptide levels. However, the mech- 
anism by which the renal tubules become refractory to the 
action of atriaI natriuretic peptide is not clear. AtriaI natri- 
uretic peptide inhibits salt reabsorption by multiple actions at 
multiple sites in the nephron (35). Perhaps a genera&d 
increase occurs in the activity of antinatriuretic systems in the 
same segment (e.g., angiotensin II in the proximal tubule or 
aldosterone in the cokcting duct, or both), or there may be an 
overwhelming increase in the activity of antinatriuretic in&- 
ences throughout the nephron (e.g., creased renaI sympa- 
thetic nerve activity). There may be sekctive reductions in 
a&n&y and/or number of atriaI natriuretic psptide receptors 
somewhere in the tubule such as occurs in heart failure, which 
is &uacterized by chronic elevated plasma levels of atria1 
natriuretic peptide (36). Alternatively, there may be an exces- 
sive degradation of filtered atrial natriuretic peptide by the 
spedic protease (endow 24.11) in the proximal con- 
voluted tubules (37). The natriuretic responsiveness to atriaI 
natriure:ic pepcide can be restored in dogs with heart failure by 
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administration of angiotensin-converting enzyme inhibitor, 
whiih suggests a role for intrarenal angiotensin II activity in 
pmmoting salt retentiun. This is an area that we are currently 
investigating with our heart transplant recipients, it is note- 
worthy’ that urodilatin, a recently discovered form of the 
cardLc natriuretic peptide family, has shown promise as a drug 
in restoring diuresis and natriuresis during the crucial early 
postoperative phase after heart transplantation (38). 
Factors influencing the development of hypertension after heart transplan- 
tation. J Heart Transplant 199&9:548-53. 
3. Bethesda Conference (24th). Cardiab Transplantation. I Am Coil Cardiol 
l993;2?:1-64. 
Sstgieal proeedares. Orthotopic heart transplantation 
does leave a portion of both recipient atria, with their accom- 
panying afferent fibers, intact. However, the functional capac- 
ity of this receptor area after transplantation is uncertain. 
Before transplantation, all the heart transplant recipients in 
this study had severe and persistent congestive heart fa;!ure, 
which is known to impair atrial stretch-receptor responses 
(39). After transplantation, the native atrial remnant is surgi- 
cally devascularixed and must rely on collateral circulation 
because the coronary artery blood source is permanently 
diverted to the donor organ. Tests of the afferent limb of the 
cardiac reflex arc are difficult to implement in humans, but we 
have observed that adenosine-induced chest pain, which re- 
quires intact cardiac afferent innervation, frequently does not 
occur in heart transplant recipients (40). Heart period variatii- 
ity, of both the donor and recipient atria, has also been used to 
assess parasympathetic activity in heart transplant recipients. 
Data from these studies indicate that parasympathetic activity 
improves but usually does not return to normal after cardiac 
transplantation (41,42). Thus, if reimiervation of the donor 
heart does occur, it is only partial, and any functionally 
important reinnervation occurs very late after transplantation 
(43,44). An additional consideration is that diastolic dysfunc- 
tion, which may be caused by a combination of factors, 
including rejection, hypertension, ischemia from allograft vas- 
culopathy and cyclosporine-associated myocardial fibrosis, 
possibly contributes to abnormal stretch receptor responses in 
the donor heart (3). 
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Condusions. Our findings permit several conclusions con- 
cerning blood pressure and fluid volume regulation in heart 
transplant recipients: 1) Arterial blood pressure in heart 
transplant recipients is salt sensitive. Therefore, management 
of heart transplant hypertension should include volume- 
depleting therapy with reduced dietary salt and appropriate 
use of diuretic drugs. 2) Although cyclosporine may contribute 
to hypertension or fluid retention, the failure to suppress 
neuroendocrine mechanisms and renal sympathetic nerve ac- 
tivity in response to acute volume expansion elicits the full 
salt-sensitive hypertensive response. 3) Abnormal cardiorenal 
neuroendocrine reflexes, secondary to cardiac denervation, are 
important modulators of blood pressure control and fluid 
volume homeostasis in heart transplant recipients. 
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